Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Virol ; 78(13): 7284-7, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15194806

RESUMO

Recent advances in class II tetramer staining technology have allowed reliable direct ex vivo visualization of antigen-specific CD4 T cells. In order to define the frequency and phenotype of a prototype response to a nonpersistent pathogen, we have used such techniques to analyze influenza virus-specific memory CD4 T cells directly from blood. These responses are stably detectable ex vivo at low frequencies (range, 0.00012 to 0.0061% of CD4 T cells) and display a distinct "central memory" CD62L(+) phenotype.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Memória Imunológica , Selectina L/metabolismo , Orthomyxoviridae/imunologia , Genes MHC da Classe II , Antígenos HLA-DR , Humanos , Fenótipo
2.
Proc Natl Acad Sci U S A ; 101(7): 1999-2004, 2004 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-14769912

RESUMO

The MHC class II molecule DQ0602 confers strong susceptibility to narcolepsy but dominant protection against type 1 diabetes. The crystal structure of DQ0602 reveals the molecular features underlying these contrasting genetic properties. Structural comparisons to homologous DQ molecules with differential disease associations highlight a previously unrecognized interplay between the volume of the P6 pocket and the specificity of the P9 pocket, which implies that presentation of an expanded peptide repertoire is critical for dominant protection against type 1 diabetes. In narcolepsy, the volume of the P4 pocket appears central to the susceptibility, suggesting that the presentation of a specific peptide population plays a major role.


Assuntos
Diabetes Mellitus Tipo 1/genética , Predisposição Genética para Doença , Antígenos HLA-DQ/química , Antígenos HLA-DQ/genética , Glicoproteínas de Membrana , Narcolepsia/genética , Alelos , Sequência de Aminoácidos , Sítios de Ligação , Cristalografia por Raios X , Cadeias beta de HLA-DQ , Humanos , Modelos Moleculares , Polimorfismo Genético/genética , Ligação Proteica , Conformação Proteica , Relação Estrutura-Atividade
3.
Eur J Immunol ; 32(12): 3366-75, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12432567

RESUMO

Reliable, efficient systems for producing soluble HLA-DR molecules, suitable for multimerization and use as staining reagents, have proved elusive. We found that the addition of a flexible linker between peptide and N terminus of the DRB1*0101-chain (Crawford, F., Kozono, H., White, J., Marrack, P. and Kappler, J., Immunity 1998. 8: 675-682.), results in greater in vitro folding efficiency of Escherichia coli-expressed alpha- and beta-chains, and increases both the yield and stability of the DRA1*0101/DRB1*0101/peptide complexes. Although a 10-amino acid linker functioned efficiently for a 20mer epitope from HIV p24, a longer linker was required to produce a DR1 MHC class II tetramer with the influenza hemagglutinin epitope (HA(306-318)). The DR1-HA tetramer was able to stain positively over 98% of a specific clone (HA 1.7) with only a brief 30-min incubation. The tetrameric complexes detected clone cells diluted into PBMC, with high sensitivity, coupled with low background staining in CD4(+) cells. It was possible to detect antigen-specific CD4(+) T cells within a population of PBMC stimulated with the HA peptide. This demonstrates the potential to monitor CD4(+) T cell responses in peripheral blood in a number of clinical scenarios.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Antígenos HLA-DR/química , Antígeno HLA-DR1/química , Células Clonais , Citometria de Fluxo , Antígenos HLA-DR/isolamento & purificação , Subtipos Sorológicos de HLA-DR , Antígeno HLA-DR1/isolamento & purificação , Humanos , Interferon gama/metabolismo , Leucócitos Mononucleares/imunologia , Substâncias Macromoleculares , Coloração e Rotulagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...